Prostate Cancer Clinical Trials in Baltimore

Showing 261-280 of 446 trials

Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention

NCT04596917

A randomized comparison clinical trial will be conducted in laparoscopic radical prostatectomy patients in the Weinberg PACU at the Johns Hopkins Hospital. 50 patients will be recruited and randomly assigned by a table of random numbers to either the music listening group (n=35) or the relaxation breathing group (n=35).

Prostate Cancer

Johns Hopkins University77 participantsStarted Oct 2020

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

NCT02655822

This is a phase 1/1b open-label, multicenter, dose-selection study of ciforadenant, an oral small molecule targeting the adenosine-A2A receptor on T-lymphocytes and other cells of the immune system. This trial will study the safety, tolerability, and anti-tumor activity of ciforadenant as a single agent and in combination with atezolizumab, a PD-L1 inhibitor against various solid tumors. Ciforadenant blocks adenosine from binding to the A2A receptor. Adenosine suppresses the anti-tumor activity of T cells and other immune cells.

Renal Cell CancerMetastatic Castration Resistant Prostate Cancer

Corvus Pharmaceuticals, Inc.502 participantsStarted Jan 2016

Tucson, Arizona, United States • San Francisco, California, United States • Stanford, California, United States +17 more locations

Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Prostate Cancer Trials in Other Cities

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

A Survivorship Care Plan and Embedded Navigation Tool

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach

Ketogenic Diet and Prostate Cancer Surveillance Pilot

Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Oral Calcitriol With Ketoconazole in CRPC

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

A Registry for Hereditary Cancer Risk Assessment and Genetic Testing

Perioperative Post-Prostatectomy Incontinence Home Telehealth Program

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Other Conditions in Baltimore